Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.

Abstract

The 5-year biochemical freedom-from-progression rates following transperineal 125I implantation are comparable with those achieved with prostatectomy. The morbidity has decreased with increased physician experience.